Ocumension Therapeutics
HKEX:1477

Watchlist Manager
Ocumension Therapeutics Logo
Ocumension Therapeutics
HKEX:1477
Watchlist
Price: 8.14 HKD 1.37% Market Closed
Market Cap: 6.6B HKD

Intrinsic Value

The intrinsic value of one Ocumension Therapeutics stock under the Base Case scenario is 9.39 HKD. Compared to the current market price of 8.14 HKD, Ocumension Therapeutics is Undervalued by 13%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
9.39 HKD
Undervaluation 13%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ocumension Therapeutics

What is Valuation History?
Ask AI Assistant
What other research platforms think about Ocumension Therapeutics?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Ocumension Therapeutics valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Ocumension Therapeutics.

Explain Valuation
Compare Ocumension Therapeutics to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Ocumension Therapeutics?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Ocumension Therapeutics

Balance Sheet Decomposition
Ocumension Therapeutics

Current Assets 817.7m
Cash & Short-Term Investments 656.2m
Receivables 173m
Other Current Assets -11.5m
Non-Current Assets 3.1B
Long-Term Investments 13.9m
PP&E 468.4m
Intangibles 2.5B
Other Non-Current Assets 103m
Current Liabilities 154.7m
Accounts Payable 140.8m
Accrued Liabilities 20.2m
Short-Term Debt 10.4m
Other Current Liabilities -16.8m
Non-Current Liabilities 89.2m
Long-Term Debt 60.9m
Other Non-Current Liabilities 28.3m
Efficiency

Free Cash Flow Analysis
Ocumension Therapeutics

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ocumension Therapeutics

Revenue
543.7m CNY
Cost of Revenue
-312.2m CNY
Gross Profit
231.5m CNY
Operating Expenses
-491.5m CNY
Operating Income
-260m CNY
Other Expenses
10.7m CNY
Net Income
-249.3m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Ocumension Therapeutics's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Operating Margin is Increasing
Strong 3Y Average Gross Margin
Healthy Gross Margin
30/100
Profitability
Score

Ocumension Therapeutics's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Ocumension Therapeutics's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Ocumension Therapeutics's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Ocumension Therapeutics

Wall Street analysts forecast Ocumension Therapeutics stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ocumension Therapeutics is 10.72 HKD with a low forecast of 10.26 HKD and a high forecast of 11.4 HKD.

Lowest
Price Target
10.26 HKD
26% Upside
Average
Price Target
10.72 HKD
32% Upside
Highest
Price Target
11.4 HKD
40% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Ocumension Therapeutics
does not pay dividends
Shareholder Yield

Current shareholder yield for Ocumension Therapeutics is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Ocumension Therapeutics stock?

The intrinsic value of one Ocumension Therapeutics stock under the Base Case scenario is 9.39 HKD.

Is Ocumension Therapeutics stock undervalued or overvalued?

Compared to the current market price of 8.14 HKD, Ocumension Therapeutics is Undervalued by 13%.

Back to Top